ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma

- Jackson, Evangeline R., Duchatel, Ryan J., Le Grand, Marion, Kearney, Padraic S., Douglas, Alicia M., Findlay, Izac J., Germon, Zacary P., McEwen, Holly P., Beitaki, Tyrone S., Patabendige, Adjanie, Skerrett-Byrne, David A., Nixon, Brett, Staudt, Dilana E., Smith, Nathan D., Day, B, Manoharan, N, Nagabushan, S, Hansford, JR, Govender, D, McCowage, GB, Firestein, R, Howlett, M, Endersby, R, Persson, Mika L., Gottardo, NG, Alvaro, F, Waszak, SM, Larsen, MR, Colino-Sanguino, Y, Valdés-Mora, F, Rakotomalala, A, Meignan, S, Pasquier, E, Andre, N, Mannan, Abdul, Hulleman, E, Eisenstat, DD, Vitanza, NA, Nazarian, J, Koschmann, C, Mueller, S, Cain, JE, Dun, MD, Yadavilli, Sridevi, Parackal, Sarah, Game, Shaye, Chong, Wai Chin, Jayasekara, W. Samantha N.

COVID-19 vaccination in children and adolescents aged 5 years and older undergoing treatment for cancer and non-malignant haematological conditions: Australian and New Zealand Children’s Haematology/Oncology Group consensus statement

- Furlong, Eliska, Kotecha, Rishi S., Phillips, Marianne B., Padhye, Bhavna, Dalla-Pozza, Luciano, Alvaro, Frank, Fraser, Christopher J., Nicholls, Wayne, Clark, Julia E., O'Connor, Matthew, Saxon, Benjamin R., Tapp, Heather, Conyers, Rachel, Heath, John, Hunter, SE, Tsui, K, Winstanley, M, Lyver, A, Best, EJ, Wadia, U, Yeoh, D, Blyth, CC, Gottardo, NG, O'Brien, Tracey A., Hansford, Jordan R., Super, Leanne, Downie, Peter, Eisenstat, David D., Haeusler, Gabrielle, McMullan, Brendan